Dashenlin Pharmaceutical Group Co., Ltd integrates pharmaceutical manufacturing, retail and wholesale, and was listed on the main board of the Shanghai Stock Exchange on July 31, 2017.

By the end of 2018, it had reached total tax sales over 10.2 billion yuan ($1.46 billion). By the third quarter of 2019, the company’s employees numbered more than 26,000 people. It has 4,256 stores in ten provinces of China, including Guangdong and Henan. 

As a brand well received by customers, Dashenlin has ranked at the top for sales in the industry throughout China for four consecutive years.